Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 21 studies | 38% ± 20% | |
ciliated cell | 20 studies | 79% ± 22% | |
fibroblast | 13 studies | 29% ± 11% | |
smooth muscle cell | 12 studies | 38% ± 21% | |
myofibroblast cell | 6 studies | 38% ± 18% | |
non-classical monocyte | 5 studies | 27% ± 8% | |
connective tissue cell | 5 studies | 32% ± 6% | |
deuterosomal cell | 4 studies | 60% ± 13% | |
epithelial cell | 4 studies | 35% ± 16% | |
podocyte | 4 studies | 82% ± 11% | |
oligodendrocyte | 4 studies | 24% ± 3% | |
retinal ganglion cell | 4 studies | 69% ± 27% | |
type II pneumocyte | 4 studies | 40% ± 17% | |
pancreatic D cell | 3 studies | 47% ± 22% | |
type B pancreatic cell | 3 studies | 37% ± 10% | |
astrocyte | 3 studies | 22% ± 5% | |
endothelial cell | 3 studies | 25% ± 3% | |
glial cell | 3 studies | 34% ± 18% | |
keratinocyte | 3 studies | 49% ± 7% | |
neuron | 3 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 5143.66 | 2470 / 2642 | 89% | 84.17 | 627 / 705 |
lung | 94% | 5064.10 | 544 / 578 | 76% | 45.09 | 878 / 1155 |
esophagus | 76% | 3921.31 | 1097 / 1445 | 81% | 40.34 | 148 / 183 |
intestine | 77% | 2953.81 | 743 / 966 | 78% | 35.27 | 410 / 527 |
kidney | 79% | 2065.00 | 70 / 89 | 69% | 32.81 | 624 / 901 |
uterus | 75% | 1982.42 | 127 / 170 | 62% | 41.01 | 286 / 459 |
breast | 62% | 1568.07 | 286 / 459 | 68% | 25.45 | 761 / 1118 |
skin | 72% | 5396.62 | 1299 / 1809 | 50% | 13.88 | 236 / 472 |
pancreas | 15% | 174.82 | 48 / 328 | 92% | 59.93 | 164 / 178 |
thymus | 38% | 688.51 | 245 / 653 | 65% | 17.28 | 395 / 605 |
stomach | 32% | 465.87 | 116 / 359 | 70% | 37.54 | 201 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 43.94 | 1 / 1 |
bladder | 38% | 892.33 | 8 / 21 | 54% | 23.04 | 274 / 504 |
prostate | 50% | 697.86 | 123 / 245 | 34% | 11.78 | 172 / 502 |
adrenal gland | 8% | 123.32 | 21 / 258 | 75% | 71.58 | 173 / 230 |
ovary | 8% | 112.92 | 15 / 180 | 70% | 38.26 | 302 / 430 |
muscle | 67% | 1670.52 | 539 / 803 | 0% | 0 | 0 / 0 |
heart | 66% | 1546.79 | 570 / 861 | 0% | 0 | 0 / 0 |
adipose | 65% | 1815.88 | 778 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 35.32 | 29 / 45 |
blood vessel | 42% | 815.63 | 563 / 1335 | 0% | 0 | 0 / 0 |
spleen | 41% | 584.27 | 99 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 24% | 12.02 | 96 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.81 | 1 / 29 |
peripheral blood | 3% | 45.02 | 24 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.50 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032273 | Biological process | positive regulation of protein polymerization |
GO_0046785 | Biological process | microtubule polymerization |
GO_0001578 | Biological process | microtubule bundle formation |
GO_0046697 | Biological process | decidualization |
GO_0007566 | Biological process | embryo implantation |
GO_0097427 | Cellular component | microtubule bundle |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005874 | Cellular component | microtubule |
GO_0015631 | Molecular function | tubulin binding |
Gene name | TPPP3 |
Protein name | Tubulin polymerization-promoting protein family member 3 (TPPP/p20) |
Synonyms | CGI-38 |
Description | FUNCTION: Regulator of microtubule dynamic that has microtubule bundling activity . Required for embryo implantation; possibly by regulating beta-catenin (By similarity). Also required for decidualization via regulation of beta-catenin . . |
Accessions | Q9BW30 ENST00000564104.5 ENST00000393957.7 ENST00000562206.1 ENST00000290942.9 |